Expression of endothelins in human cardiogenesis.
Genetic disruption of endothelin (ET) 1, endothelin-converting enzyme (ECE) 1, and endothelin receptor A (ET(A)) in "knockout" or mutant mouse models result in defects in branchial arch derived craniofacial tissues and in cardiac outflow and great vessel structures. Interestingly, certain types of human congenital cardiovascular malformations such as Catch 22 syndrome and type B interruption of the aortic arch strongly resemble defects seen in knockout animal models. To better address the exact involvement of the ET system in heart formation we explored the spatiotemporal pattern of expression of the components of the ET system during critical phases of cardiogenesis in the human embryo (3-6 weeks of development; Carnegie stages 10-17) by in situ hybridization. We detected high ET-1 mRNA expression in endocardial cells lining the heart outflow tract in the region where the future aortic valves will form. No hybridization signal corresponding to pre-pro-ET-3 was observed in the heart. At the same location, the underlying myocytes express ET(A) mRNA. Whereas a functional role of ET in the valve formation can be proposed because of the simultaneous presence of all the components of the endothelin system (ET-1/ECE-1/ET(A)), this seems not to be the case for the formation of the ventricular septum where endocardial cells do not express ET-1, and only a weak ET(A) hybridization signal was detected in the surrounding myocardium. An abnormal hemodynamism indirectly due to valve malformation may be the indirect cause of this septal defect. The results of this study suggest an important role for the ET system in the formation of certain anatomical structures of the developing human heart.
Brand
Marcus
M
Collège de France, INSERM U36, 11 Place Marcelin Berthelot, 75231 Paris Cedex 05, France.
Kempf
Hervé
H
Paul
Martin
M
Corvol
Pierre
P
Gasc
Jean-Marie
JM
D001013:Aorta, Thoracic / Q000196:embryology*; D016282:Aspartic Acid Endopeptidases; D019332:Endothelin-1 / Q000235:genetics / Q000378:metabolism*; D019333:Endothelin-2 / Q000235:genetics / Q000378:metabolism*; D000072396:Endothelin-Converting Enzymes; D005260:Female; D005318:Fetal Heart / Q000196:embryology / Q000378:metabolism* / Q000502:physiology; D018507:Gene Expression Regulation, Developmental; D015971:Gene Expression Regulation, Enzymologic; D006330:Heart Defects, Congenital / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D006345:Heart Septal Defects, Ventricular; D006801:Humans; D017403:In Situ Hybridization; D066298:In Vitro Techniques; D008666:Metalloendopeptidases; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
D019332:Endothelin-1; D019333:Endothelin-2; D012333:RNA, Messenger; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; C000606923:ECE1 protein, human; C000606925:Ece1 protein, mouse; D000072396:Endothelin-Converting Enzymes